Autobio Diagnostics Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Autobio Diagnostics Co Ltd with three other
companies in this sector in CHINA :
Jiangsu Kanion Pharmaceutical Co., Ltd.
sales of 3.03 billion Chinese Renmimbi [US$471.01 million]
of which 26%
was Domestic Sales of Industrial Enterprises),
Xiangxue Pharmaceutical Co Ltd
(3.06 billion Chinese Renmimbi [US$475.35 million]
Harbin Gloria Pharmaceuticals Co., Ltd
(3.02 billion Chinese Renmimbi [US$468.62 million]
During the year ended December of 2020, sales at
Autobio Diagnostics Co Ltd were 2.98 billion Chinese Renmimbi (US$462.65 million).
increase of 11.1%
versus 2019, when the company's sales were 2.68 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Autobio Diagnostics Co Ltd
(and since 2015, sales have increased a total of 316%).
Sales of In Vitro Diagnosis saw an increase
11.3% in 2020, from
2.60 billion Chinese Renmimbi to 2.90 billion Chinese Renmimbi.